This article was first published by TrialSiteNews behind a paywall. Merck’s Molnupiravir (also known as EIDD-2801 and MK-4482) is a mutagenic nucleotide analogue [1]. It introduces errors in the SARS-COV-2 RNA at the time of replication after proofreading, and causes lethal mutagenesis [2]. This threatens to accelerate the evolution of the coronavirus. Any major variant … Continue reading Is Molnupiravir a Global Catastrophic Threat?